Skip to content

EBITDA at other companies

Altimmune logo
AltimmuneALT
-$24.22M-11.2%
Wave Life Sciences logo
Wave Life SciencesWVE
-$30.46M+37.8%
Prime Medicine logo
Prime MedicinePRME
-$48.8M+3.7%
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
-$43.68M-16.0%
Eli Lilly logo
Eli LillyLLY
Amgen logo
AmgenAMGN

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Calculated from Vivani Medical’s reported figures.

$6.8Mebit+
$130.0KDepreciation Depletion & Amortization
=-$6.69M

The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's EBITDA?
Vivani Medical (VANI) reported EBITDA of -$6.69M in Q1 2026.
How has Vivani Medical's EBITDA changed year-over-year?
Vivani Medical's EBITDA decreased by 3.6% year-over-year, from -$6.46M to -$6.69M.
What is the long-term trend for Vivani Medical's EBITDA?
Over 4 years (2021 to 2025), Vivani Medical's EBITDA has grown at a 29.8% compound annual growth rate (CAGR), from -$9.57M to -$27.13M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.